Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding

Crit Care Med. 2000 Jul;28(7):2334-7. doi: 10.1097/00003246-200007000-00026.

Abstract

Objective: To evaluate the effect of intravenous erythromycin on gastric emptying and the success of enteral feeding in mechanically ventilated, critically ill patients with large volume gastric aspirates.

Design: Prospective, double-blind, randomized, and placebo-controlled trial.

Setting: General intensive care unit in a university hospital.

Patients: Twenty critically ill, mechanically ventilated patients intolerant of nasogastric feeding (indicated by a residual gastric volume of > or =250 mL during feed administration at > or =40 mL/hr).

Interventions: After a gastric aspirate of > or =250 mL, which was discarded, the enteral feeding was continued at the previous rate for 3 hrs. Intravenous erythromycin (200 mg) or placebo was then administered over 20 mins. The residual gastric contents were again aspirated and the volume was recorded 1 hr after the infusion began.

Measurements and main results: Gastric emptying was calculated as volume of feed infused into the stomach over 4 hrs minus the residual volume aspirated. Mean gastric emptying was 139+/-37 (+/-SEM) mL after erythromycin and -2+/-46 mL after placebo (p = .027). Nasogastric feeding was successful in nine of ten patients treated with erythromycin and five of ten who received placebo 1 hr after infusion (chi-square p = .05).

Conclusion: In critically ill patients who have large volumes of gastric aspirates indicating a failure to tolerate nasogastric feeding, a single small dose of intravenous erythromycin allows continuation of feed in the short term.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • APACHE
  • Critical Care*
  • Double-Blind Method
  • Enteral Nutrition
  • Erythromycin / administration & dosage
  • Erythromycin / therapeutic use*
  • Female
  • Gastric Emptying / drug effects*
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Intubation, Gastrointestinal / adverse effects*
  • Male
  • Middle Aged
  • Respiration, Artificial

Substances

  • Gastrointestinal Agents
  • Erythromycin